As patent-related controversies intensify, lawmakers in the U.S. have also raised concerns over whether similar tactics inflate prescription drug costs, creating a significant barrier for generic alternatives and impacting public health budgets.
- America
- And More
- Arizona
- Brand Stories
- Business
- California News
- Florida
- Florida News
- International
- Investigates
- Legal Industry
- New York News
- Opinion
- Pennsylvania
- Premium
- Tallahassee
- The People's Voice
- U.S. News
- USA Herald
